Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 11

1.

111In-Labeled 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-d-Tyr-d-Lys(HSG)-d-Glu-d-Lys(HSG)-NH2 (IMP-288).

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Jun 29 [updated 2011 Aug 25].

2.

Cancer radioimmunotherapy.

Sharkey RM, Goldenberg DM.

Immunotherapy. 2011 Mar;3(3):349-70. doi: 10.2217/imt.10.114. Review.

3.

Radioactive antibodies: a historical review of selective targeting and treatment of cancer.

Goldenberg DM, Sharkey RM.

Hosp Pract (1995). 2010;38(3):82-93. doi: 10.3810/hp.2010.06.300. Review.

PMID:
20890056
4.

Detection of early-stage pancreatic adenocarcinoma.

Gold DV, Goggins M, Modrak DE, Newsome G, Liu M, Shi C, Hruban RH, Goldenberg DM.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2786-94. doi: 10.1158/1055-9965.EPI-10-0667. Epub 2010 Sep 1.

5.

Biological evaluation of avidin-based tumor pretargeting with DOTA-Triazole-Biotin constructed via versatile Cu(I) catalyzed click chemistry.

Uppal JK, Varshney R, Hazari PP, Chuttani K, Kaushik NK, Mishra AK.

J Drug Target. 2011 Jul;19(6):418-26. doi: 10.3109/1061186X.2010.504269. Epub 2010 Aug 3.

PMID:
20678008
6.

Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.

Liu G, Dou S, Pretorius PH, Liu X, Chen L, Rusckowski M, Hnatowich DJ.

Q J Nucl Med Mol Imaging. 2010 Jun;54(3):333-40. Epub 2009 Dec 15.

7.

Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold.

Ahlgren S, Orlova A, Wållberg H, Hansson M, Sandström M, Lewsley R, Wennborg A, Abrahmsén L, Tolmachev V, Feldwisch J.

J Nucl Med. 2010 Jul;51(7):1131-8. doi: 10.2967/jnumed.109.073346. Epub 2010 Jun 16.

8.

A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.

Gold DV, Goldenberg DM, Karacay H, Rossi EA, Chang CH, Cardillo TM, McBride WJ, Sharkey RM.

Cancer Res. 2008 Jun 15;68(12):4819-26. doi: 10.1158/0008-5472.CAN-08-0232.

9.
10.

Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.

Cardillo TM, Karacay H, Goldenberg DM, Yeldell D, Chang CH, Modrak DE, Sharkey RM, Gold DV.

Clin Cancer Res. 2004 May 15;10(10):3552-61.

11.

Localization of pancreatic cancer with radiolabeled monoclonal antibody PAM4.

Gold DV, Cardillo T, Goldenberg DM, Sharkey RM.

Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):147-54.

PMID:
11418312

Supplemental Content

Support Center